2019 annual financial data
Aytu BioPharma 2019 Operating margin
Direct answer
Operating margin was -230.13%.
Operating income was -16,846,637 USD and net income was -47,166,950 USD.
Operating cash flow was -13,831,377 USD.
Get free Aytu BioPharma email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 7,320,357 USD
- Operating income
- -16,846,637 USD
- Net income
- -47,166,950 USD
- Operating cash flow
- -13,831,377 USD